ACADIA PHARMACEUTICALS INC Logo

ACADIA PHARMACEUTICALS INC

Biopharmaceutical company developing medicines for CNS disorders and rare diseases.

ACAD | US

Overview

Corporate Details

ISIN(s):
US0042251084
LEI:
Country:
United States of America
Address:
12830 EL CAMINO REAL, 92130 SAN DIEGO

Description

ACADIA PHARMACEUTICALS INC. is a biopharmaceutical company focused on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases. The company's commercial portfolio includes FDA-approved treatments for Parkinson's disease psychosis and Rett syndrome. Acadia is advancing a diverse clinical pipeline with mid- to late-stage programs targeting conditions such as Alzheimer's disease psychosis and Lewy body dementia psychosis, alongside early-stage programs addressing other unmet patient needs. The company's mission is to provide innovative therapies and support to underserved patient communities.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2023-04-07 22:37
FORM 4 SUBMISSION
English ZIP 7.8 KB
2023-04-07 22:34
FORM 4 SUBMISSION
English ZIP 7.7 KB
2023-04-07 22:32
FORM 4 SUBMISSION
English ZIP 7.8 KB
2023-03-13 07:11
8-K
English ZIP 60.8 KB
2023-02-27 22:00
FORM 4 SUBMISSION
English ZIP 7.3 KB
2023-02-27 22:00
FORM 4 SUBMISSION
English ZIP 7.3 KB
2023-02-27 22:00
FORM 4 SUBMISSION
English ZIP 7.3 KB
2023-02-27 22:00
FORM 4 SUBMISSION
English ZIP 7.3 KB
2023-02-27 22:00
FORM 4 SUBMISSION
English ZIP 7.3 KB
2023-02-27 19:38
10-K
English ZIP 3.5 MB
2023-02-27 19:32
8-K
English ZIP 110.3 KB
2023-02-14 13:38 English ZIP 9.5 KB
2023-02-13 19:45
FORM 4 SUBMISSION
English ZIP 7.5 KB
2023-02-13 19:40
FORM 3 SUBMISSION
English ZIP 8.2 KB
2023-02-09 11:54
SCHEDULE 13G/A
English ZIP 10.9 KB

Automate Your Workflow. Get a real-time feed of all ACADIA PHARMACEUTICALS INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ACADIA PHARMACEUTICALS INC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ACADIA PHARMACEUTICALS INC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Biofrontera AG Logo
Biopharmaceutical firm specializing in photodynamic therapy for skin conditions.
Germany
B8F
Biofrontera Inc. Logo
A biopharmaceutical company commercializing products for dermatological conditions.
United States of America
BFRI
BioGaia Logo
A healthcare and biotechnology company developing clinically proven probiotic products.
Sweden
BIOG
BIOGEN INC. Logo
Biotechnology company developing therapies for neurological and neurodegenerative diseases.
United States of America
BIIB
Bio Green Med Solution, Inc. Logo
A diversified company in the biopharmaceutical and fire safety sectors.
United States of America
BGMS
BIOHARVEST SCIENCES INC. Logo
A biotech firm using a platform to grow plant cells for health and wellness products.
United States of America
BHST
Biohaven Ltd. Logo
Develops therapies for neuroscience, immunology, and oncology for unmet medical needs.
United States of America
BHVN
BioInvent International Logo
Develops novel, first-in-class immuno-modulatory antibodies for cancer therapy.
Sweden
BINV
BIOLIFE SOLUTIONS INC Logo
Manufactures biopreservation media and tools for cell and gene therapy markets.
United States of America
BLFS
BioLineRx Ltd. Logo
A clinical-stage biopharmaceutical company developing therapies for oncology and rare diseases.
Israel
BLRX

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.